Position in ANNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$80,605,714
+$30,151,482 QoQ
Shares Held
14,549,768
+44.8% QoQ
Ownership
7.29%
of shares outstanding
% of Portfolio
5.34%
of 13F equity value
Holder Rank
#1
of 216 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Redmile Group, LLC holds $1,432,283,191 across 31 Biotechnology names. ANNX ranks #6 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
9,066,621 | $445,715,088 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
673,505 | $173,979,811 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
|
4,164,120 | $135,583,747 | |
| 4 | IMNM |
Immunome Inc.
|
5,558,885 | $121,572,814 | |
| 5 | NRIX |
Nurix Therapeutics, Inc.
|
7,732,808 | $119,858,524 | |
| 6 | ANNX |
Annexon, Inc.
This page
|
14,549,768 | $80,605,714 | |
| 7 | RGNX |
REGENXBIO Inc.
|
4,368,804 | $36,610,577 | |
| 8 | STTK |
Shattuck Labs, Inc.
|
5,539,724 | $35,620,425 |
All Filings in ANNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $80,605,714 | 14,549,768 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $50,454,232 | 10,050,644 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,216,964 | 6,300,644 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,121,545 | 6,300,644 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,160,242 | 6,300,644 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $32,322,303 | 6,300,644 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $38,050,575 | 6,427,462 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,494,563 | 6,427,462 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $39,457,872 | 5,503,190 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $24,984,482 | 5,503,190 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,267,528 | 3,503,190 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,331,228 | 3,503,190 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,487,281 | 3,503,190 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,111,492 | 3,503,190 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $21,649,714 | 3,503,190 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,207,026 | 3,503,190 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,743,963 | 3,202,917 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $37,100,256 | 3,228,917 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $62,328,332 | 3,349,185 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $77,097,605 | 3,425,038 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $96,293,827 | 3,458,830 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $86,304,190 | 3,448,030 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $104,055,348 | 3,442,122 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||